Ignite Creation Date:
2024-05-06 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03538171
Status:
UNKNOWN
Last Update Posted:
2021-07-09
First Post:
2018-04-27
Brief Title:
Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Taizhou EOC Pharma Co Ltd
Organization:
Taizhou EOC Pharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-27
First Submit QC Date:
May 15 2018
Study First Post Date:
2018-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-07
Last Update Post Date:
2021-07-09
Last Update Post Date Type:
ACTUAL